biosingularity
The substrate determines the ceiling — verify a biomedical claim.
Every verdict carries a receipt. Funding provenance spans 8 sources and the top 740 research funders — depth for ~70% of their grant funding, a canonical identity for ~88%.
DOIs are extracted offline; each is resolved against PubMed and checked for retraction, correction, and provenance. Nothing is asserted without a receipt.
Local NER extracts the disease, drug, and gene entities, then verifies each: genes against Open Targets genetic evidence, drugs against ChEMBL. Nothing is asserted without a receipt.
Checks the target against Open Targets — genetic association, known-drug, and literature evidence. A weak or absent association is flagged, not hidden.
Checks a drug against ChEMBL (market withdrawal, FDA black-box warning) and a trial against ClinicalTrials.gov (terminated / withdrawn / suspended early). Nothing is asserted without a receipt.